Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and …
R Thiruvengadam, A Awasthi, G Medigeshi… - The Lancet Infectious …, 2022 - thelancet.com
Background SARS-CoV-2 variants of concern (VOCs) have threatened COVID-19 vaccine
effectiveness. We aimed to assess the effectiveness of the ChAdOx1 nCoV-19 vaccine …
effectiveness. We aimed to assess the effectiveness of the ChAdOx1 nCoV-19 vaccine …
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19
NA Makoah, T Tipih, MM Litabe, M Brink… - Future …, 2022 - Taylor & Francis
Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
COVID-19 diagnostics: Molecular biology to nanomaterials
The SARS-CoV-2 pandemic has claimed around 6.4 million lives worldwide. The disease
symptoms range from mild flu-like infection to life-threatening complications. The …
symptoms range from mild flu-like infection to life-threatening complications. The …
Sub-optimal neutralisation of omicron (B. 1.1. 529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6 …
GR Medigeshi, G Batra, DR Murugesan… - …, 2022 - thelancet.com
Background Rapid spread of the omicron SARS-CoV-2 variant despite extensive
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …
Cross-reactivity of SARS-CoV-2 nucleocapsid-binding antibodies and its implication for COVID-19 serology tests
A Rak, S Donina, Y Zabrodskaya, L Rudenko… - Viruses, 2022 - mdpi.com
The emergence of the new coronavirus SARS-CoV-2 in late 2019 led to the global
pandemic COVID-19, causing a profound socioeconomic crisis. Adequate diagnostic tools …
pandemic COVID-19, causing a profound socioeconomic crisis. Adequate diagnostic tools …
Antibody response to BNT162b2 mRNA vaccine in gingival crevicular fluid
Background This prospective cohort study aimed to evaluate the antibody responses in non‐
invasive gingival crevicular fluid (GCF) and unstimulated whole saliva to the SARS‐CoV‐2 …
invasive gingival crevicular fluid (GCF) and unstimulated whole saliva to the SARS‐CoV‐2 …
Salivary SARS-CoV-2 antibody detection using S1-RBD protein-immobilized 3D melt electrowritten poly (ε-caprolactone) scaffolds
Sensitive detection of immunoglobulin antibodies against SARS-CoV-2 during the COVID-
19 pandemic is critical to monitor the adaptive immune response after BNT162b2 mRNA …
19 pandemic is critical to monitor the adaptive immune response after BNT162b2 mRNA …
[HTML][HTML] Longitudinal serology of SARS-CoV-2-infected individuals in India: a prospective cohort study
R Thiruvengadam, S Chattopadhyay… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Clinical and epidemiological characteristics of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are now widely available, but there are few data regarding …
coronavirus 2 (SARS-CoV-2) are now widely available, but there are few data regarding …
Diagnostic tools for rapid screening and detection of SARS-CoV-2 infection
The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has severely impacted human health and the …
syndrome coronavirus 2 (SARS-CoV-2), has severely impacted human health and the …
Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2
The zoonotic SARS-CoV-2 virus was present before the onset of the pandemic. It undergoes
evolution, adaptation, and selection to develop variants that gain high transmission rates …
evolution, adaptation, and selection to develop variants that gain high transmission rates …